In a young woman with generalized lymphadenopathy, night sweats, neutrophilic leukocytosis, and elevated ferritin, how should I work up for cytomegalovirus (CMV) and Epstein‑Barr virus (EBV) infection?

CMV and EBV Work-Up in Young Woman with Lymphadenopathy, Night Sweats, and Elevated Ferritin

In this clinical scenario, start with EBV serologies (VCA IgM, VCA IgG, and EBNA) and CMV IgM/IgG antibodies as your first-line diagnostic tests, but recognize that this presentation with neutrophilic leukocytosis and elevated ferritin is atypical for simple viral mononucleosis and warrants broader investigation for malignancy and hemophagocytic lymphohistiocytosis (HLH).

Initial Diagnostic Approach

EBV Testing Algorithm

According to IDSA/ASM guidelines, the diagnostic sequence for EBV should proceed as follows 1:

• Skip the heterophile/Monospot test in this case—it has a 10% false-negative rate and can be falsely positive with CMV infection, leukemia, and other conditions 1
• Order EBV-specific antibody panel directly: VCA IgM, VCA IgG, and EBNA antibodies on serum
  • VCA IgM positive (with or without VCA IgG) + EBNA negative = recent primary EBV infection 1
  • EBNA antibodies present = infection occurred >6 weeks ago, making EBV unlikely as the acute cause 1
  • Note: 5-10% of EBV-infected patients never develop EBNA antibodies 1

CMV Testing Algorithm

For CMV evaluation in this immunocompetent patient 1:

• Order CMV IgM and IgG antibodies as the first-line test
  • CMV IgM positive = recent infection
  • CMV IgG alone = past exposure only
  • Critical caveat: CMV IgM can be falsely positive in patients with EBV infection or other causes of immune activation 1—this is particularly relevant given your patient's presentation

Important Clinical Red Flags in This Case

This Presentation Suggests More Than Simple Mononucleosis

Your patient's constellation of findings is concerning for alternative or complicating diagnoses:

• Neutrophilic leukocytosis is atypical—EBV and CMV typically cause lymphocytosis with atypical lymphocytes 1, 2
• Elevated ferritin with systemic symptoms raises concern for:
  • Hemophagocytic lymphohistiocytosis (HLH), which can be triggered by EBV or CMV 3
  • Malignancy (lymphoma, leukemia)—EBV is associated with lymphoproliferative disease 1
  • Note: EBV can directly modulate ferritin expression 4

Additional Work-Up Required Beyond Viral Serologies

Given the atypical features, you must simultaneously pursue:

1. Complete blood count with manual differential to look for atypical lymphocytes (expected in viral mononucleosis) versus blasts or other abnormal cells
2. Comprehensive metabolic panel including liver enzymes and LDH (elevated LDH predicts complications 5)
3. HLH screening criteria if ferritin is markedly elevated (>500 ng/mL):
   • Triglycerides, fibrinogen, soluble IL-2 receptor
   • Consider bone marrow examination for hemophagocytosis 3
4. Lymph node biopsy should be strongly considered given generalized lymphadenopathy with this atypical presentation—this can diagnose lymphoma and detect EBV-associated lymphoproliferative disease, which requires demonstration of EBV DNA, RNA, or protein in tissue 1

When to Consider Advanced Testing

EBV Viral Load (NAAT/PCR)

Do not routinely order EBV PCR in immunocompetent patients 1. Reserve EBV DNA quantification for:

• Immunocompromised patients at risk for EBV-associated lymphoproliferative disease
• When tissue diagnosis suggests EBV-associated malignancy
• Specimen: whole blood, peripheral blood lymphocytes, or plasma in EDTA tube 1

CMV Viral Load

CMV PCR is not indicated in immunocompetent hosts 1. It is reserved for:

• Transplant recipients for preemptive therapy monitoring
• Immunocompromised patients with CMV disease

Clinical Differentiation: CMV vs. EBV Mononucleosis

If viral mononucleosis is confirmed, these features help distinguish the etiology 2:

CMV mononucleosis characteristics:

• Older age (median 34 years vs. 20 years for EBV)
• Prolonged fever (median 14 days vs. 5 days)
• Absence of sore throat, pharyngitis, and cervical lymphadenopathy
• Less prominent tonsillar enlargement

EBV mononucleosis characteristics:

• Younger patients (adolescents/young adults)
• Classic triad: fever, pharyngitis, cervical lymphadenopathy
• Tonsillar enlargement common

Co-infection Considerations

Co-infection with both CMV and EBV occurs in 10-14% of mononucleosis cases 6, 7. This can represent:

• Near-simultaneous infections
• Acute CMV triggering EBV reactivation 6

Critical Pitfalls to Avoid

1. Do not assume viral mononucleosis based on symptoms alone when neutrophilic leukocytosis and elevated ferritin are present—these findings demand exclusion of HLH and malignancy
2. Do not rely on heterophile testing in complex cases—go directly to specific serologies 1
3. Do not interpret positive CMV IgM in isolation—it can be falsely positive with EBV infection 1
4. Do not order viral PCR tests in immunocompetent patients unless tissue diagnosis or severe complications warrant it 1
5. Do not delay lymph node biopsy if the clinical picture remains unclear after initial serologic testing—EBV-associated lymphoproliferative disease requires tissue diagnosis 1

Specimen Collection Details

When ordering tests, specify 1:

• Serum for antibodies: clot tube, room temperature, <2 hours
• Whole blood for PCR (if needed): EDTA (lavender top), room temperature, <2 hours
• Do not use plasma preparation tubes for viral PCR